ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Net income 2022–2025
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.5MFY2025 · since FY2022: $3.3M → -$24.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.5M | -1768.9% |
| FY2024 | -$1.3M | -129.3% |
| FY2023 | $4.5M | +33.6% |
| FY2022 | $3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASBP financial trends
ASBP RevenueASBP Net marginASBP Gross profitASBP Gross marginASBP Operating incomeASBP Operating marginASBP Operating cash flowASBP Free cash flowASBP Capital expendituresASBP Return on equityASBP Stock buybacksASBP Dividends paidASBP Total assetsASBP Total liabilitiesASBP Shareholders’ equityASBP overview →